HAE vs LYB · P/E 35, rev $1.33B vs P/E 21, rev $16.37B
Haemonetics Corporation (HAE) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the HAE and LYB stock pages for the full models.
Not investment advice.